The University of Cambridge, the Royal College of Physicians, London (RCP) and the Sunway Group have launched a collaborative continuing medical education (CME) seminar series for Malaysian healthcare professionals.
Having supportive family relationships may help youth maintain good asthma management behaviours despite difficult neighbourhood conditions--thus serving as a buffer against poor asthma outcomes associated with living in disorderly neighbourhoods, a recent study finds.
The cut-off value of the STOP-BANG, a simple screening tool for obstructive sleep apnoea (OSA), for neck circumference can be maintained at 40 cm in Asian males but should be lowered to 35 cm in Asian females, according to a Singapore study.
A recently published analysis of the world’s largest genome-wide association study (GWAS) of lung cancer among female never-smokers found a set of tuberculosis (TB)-related genes associated with lung adenocarcinoma in Asian women.
High partial pressure of carbon dioxide (PaCO2) and age, low body mass index (BMI), and previous admission for exacerbations of chronic obstructive pulmonary disease (ECOPD) in the last 2 years strongly predict 90-day mortality in patients with severe COPD, according to the Classification and Regression Tree (CART) analysis of a recent study.
A pulmonary artery diameter to ascending aorta diameter ratio (PA/A) ≥1 during acute exacerbation (AE) is a predictor of poor survival outcomes in patients with fibrotic interstitial lung disease (f-ILD), suggest the results of a recent study.
Using point-of-care testing (POCT) of C-reactive protein (CRP) to guide antibiotic prescribing in primary care clinics led to reduced antibiotic use for acute exacerbations of chronic obstructive pulmonary disease (COPD) without compromising clinical outcomes, the PACE* study finds.
Due to the apparent risk of adverse outcomes of disease and adverse events (AEs) associated with short-acting beta-agonists (SABA), the Global Initiative for Asthma (GINA) 2019 guideline recommends that all patients with mild asthma should receive symptom-driven or regular low-dose inhaled corticosteroid (ICS)−containing controller treatment.